Multimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical Prostatectomy

Prostate cancer is the most common cancer in Australian men. Robot-assisted radical prostatectomy (RARP) - surgical removal of the prostate - is a standard treatment, but it frequently causes erectile dysfunction (ED) and urinary incontinence that can persist for years and significantly affect quality of life. This trial (ROBOPREP) will test whether a multimodal program of prehabilitation (before surgery) and rehabilitation (after surgery) improves erectile function and urinary continence in men undergoing RARP, compared to standard care alone. The program includes four components, all deliv

Trial Details

NCT ID
NCT07576335
Phase
PHASE2
Sponsor
Surgical Outcomes Research Centre (SOuRCe)
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Tadalafil 5 mg
  • Pelvic Floor Muscle Training (PFMT)
  • Aerobic Exercise Program
  • Nutritional Recommendations
  • Psychological and Wellbeing Strategies
  • Standard Perioperative Care
Locations (sample)
  • Sydney, New South Wales, Australia|-33.86785,151.20732
  • Sydney, New South Wales, Australia|-33.86785,151.20732
  • Sydney, New South Wales, Australia|-33.86785,151.20732

Key Eligibility Criteria

  • Adults aged ≥18 years undergoing elective robot-assisted radical prostatectomy (RARP) with curative intent for confirmed prostate cancer.
  • Consulting a urological surgeon with an appointment at participating sites at least 4 weeks prior to scheduled surgery.
  • Willingness to engage in prescribed self-directed interventions.
  • Expected to have 100% unilateral OR \>50% bilateral nerve sparing at prostatectomy

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →